Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections.
about
Peste des petits ruminantsThe evolution of poxvirus vaccinesA novel recombinant Peste des petits ruminants-canine adenovirus vaccine elicits long-lasting neutralizing antibody response against PPR in goatsReview: Capripoxvirus Diseases: Current Status and Opportunities for Control.Antigenic and immunogenic investigation of B-cell epitopes in the nucleocapsid protein of peste des petits ruminants virusPeste des petits ruminants virus infection of small ruminants: a comprehensive review.Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep.Self-assembly and release of peste des petits ruminants virus-like particles in an insect cell-baculovirus system and their immunogenicity in mice and goats.Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccineDisease properties, geography, and mitigation strategies in a simulation spread of rinderpest across the United States.Recombinant DNA technology for producing new rinderpest virus vaccines.Determination of the minimum fully protective dose of adenovirus-based DIVA vaccine against peste des petits ruminants virus challenge in East African goats.Diagnosis and control of peste des petits ruminants: a comprehensive review.Peste des petits ruminants virus tissue tropism and pathogenesis in sheep and goats following experimental infection.Vaccines against peste des petits ruminants virus.Animal poxvirus vaccines: a comprehensive review.Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach.Development of a helper cell-dependent form of peste des petits ruminants virus: a system for making biosafe antigen.Sheeppox virus kelch-like gene SPPV-019 affects virus virulence.Identification and functional analysis of the GTPV bidirectional promoter region.Recombinant Sheep Pox Virus Proteins Elicit Neutralizing AntibodiesDNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.Impact and Epidemiological Investigations into the Incursion and Spread of Peste des Petits Ruminants in the Comoros Archipelago: An Increased Threat to Surrounding Islands.Immunogenicity of the capsid precursor and a nine-amino-acid site-directed mutant of the 3C protease of foot-and-mouth disease virus coexpressed by a recombinant goatpox virus.Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.Scientific Opinion on peste des petits ruminantsThe Gene of Goatpox Virus Encodes an Inhibitor of NF-κB and Apoptosis and May Serve as an Improved Insertion Site To Generate Vectored Live VaccineBovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell Responses
P2860
Q26786685-F4723C66-C714-4ACD-A40B-51E45332B1E5Q26995905-2EF50C92-2F5B-4324-98FA-A3C23CA88B42Q28729865-5C0BA44E-3333-4A19-885F-A684FB6505EAQ30252040-F8CBA971-CBE8-4D7D-AD5E-3724D01788BEQ33594144-9AFDD885-B114-4772-8572-BB2178F6AF9FQ33820705-1F98D847-22FB-4D5D-8DBF-41310EBB242CQ33889779-D6AB421F-7112-4F61-BD7F-6F59A2F50D2BQ34035499-26A2D745-B389-4ED7-A878-D28460C48343Q34431934-992A679C-5C26-4ED4-9C2E-E5F4D510440DQ34774315-AAE152D3-90FE-401D-9666-2A28113842ABQ36066267-66B65D29-67B5-4BE9-91DF-3CDDE910A6BBQ36485614-072B99FA-DCCB-4440-86AC-820698F44C40Q37468037-510FD50D-A8A6-444B-9E25-3BE3F0E88637Q37534284-C68AFD04-1872-4AC0-AEE3-B4E73C6ECE9DQ37771946-CDC3BB3C-69D8-44CC-9F7F-6DA140D3F96CQ38068233-5718E14B-6029-4C1A-9887-2C9EF83F5ACBQ38364597-886B930E-1A7D-4EC4-ABE5-946B19AF3972Q38833411-504EF299-E37D-4AF0-B67D-53A8FFA490F9Q40442408-DAEB3F32-EA1A-4C86-ACA7-AE7FF41F25AAQ40490245-CC50BFB8-10BF-46A8-A323-E47A76736D81Q40684847-117C38DD-7FE5-4347-B8A5-474E2DC6D994Q40864230-C132478E-F66D-4293-89B1-A385BC7906E1Q41645219-7CB8618C-CB4C-49A7-A45B-80EA4A701E57Q42240435-A611FA03-8FD7-43EE-8CDE-808D7C9B11CEQ45324559-E0F274F9-7A9C-488A-A1A6-C0893B3AFD7AQ47156678-FD1A798E-7DF3-4478-B36D-0C89D7A1305EQ56556724-A0C14201-C123-47E0-A1A6-0B8D86AAE41CQ56902462-5078B2A9-620E-4657-B5CD-E4FA73C9C5B4
P2860
Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Development of a dual recombin ...... and capripoxvirus infections.
@en
Development of a dual recombin ...... and capripoxvirus infections.
@nl
type
label
Development of a dual recombin ...... and capripoxvirus infections.
@en
Development of a dual recombin ...... and capripoxvirus infections.
@nl
prefLabel
Development of a dual recombin ...... and capripoxvirus infections.
@en
Development of a dual recombin ...... and capripoxvirus infections.
@nl
P2093
P2860
P1433
P1476
Development of a dual recombin ...... and capripoxvirus infections.
@en
P2093
Ngangnou A
P2860
P304
P356
10.1128/JVI.77.2.1571-1577.2003
P407
P577
2003-01-01T00:00:00Z